Grace Therapeutics (GRCE) EBITDA Yield: History & Chart

Basis: Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The EBITDA yield is N/A as of 2026-10-06T16:42:29.618Z.

Stored calculation inputs

Calculation as of: 2026-10-06T16:42:29.618Z.

Quote observation: 2026-10-06T16:40:01.000Z. Amounts in USD. The price header may show a later quote.

TTM operating EBITDA · period ending 2026-06-30: -25,678,108
Quote market capitalization: 34,339,822
Total debt · period ending 2026-06-30: 0
Cash · period ending 2026-06-30: 13,756,000

FMP input reference: 451a64ce4da380df6ab4c5027584c6fd3c25ecc0cb3c19eab7daced69cd0f5b9

EV/EBITDA|Earnings Yield|OCF Yield|FCF Yield|All Metrics

GRCE EBITDA Yield Metrics

EBITDA YIELD

N/A

GRCE Competitors' EBITDA Yield

GRCE

Grace Therapeutics, Inc.

Current

Market Cap

$34.34M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ARAY

Accuray Incorporated

vs GRCE

Market Cap

$34.20M

EBITDA Yield

N/A

TTM Avg

4.27%

3Y Avg

2.75%

5Y Avg

3.74%

ALGS

Aligos Therapeutics, Inc.

vs GRCE

Market Cap

$33.66M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BCTX

BriaCell Therapeutics Corp.

vs GRCE

Market Cap

$35.10M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ELUT

Elutia Inc

vs GRCE

Market Cap

$35.15M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

DCGO

DocGo Inc.

vs GRCE

Market Cap

$35.76M

EBITDA Yield

N/A

TTM Avg

15.63%

3Y Avg

9.19%

5Y Avg

7.93%

EUDA

EUDA Health Holdings Limited

vs GRCE

Market Cap

$32.91M

EBITDA Yield

N/A

TTM Avg

0.01%

3Y Avg

0.01%

5Y Avg

0.01%

RMTI

Rockwell Medical, Inc.

vs GRCE

Market Cap

$32.64M

EBITDA Yield

N/A

TTM Avg

5.17%

3Y Avg

5.17%

5Y Avg

5.17%

BEAT

HeartBeam, Inc.

vs GRCE

Market Cap

$32.34M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SCLX

Scilex Holding Company

vs GRCE

Market Cap

$32.27M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EBITDA YIELD	TTM	3Y	5Y
Grace Therapeutics, Inc. (GRCE)	$34.34M	N/A	N/A	N/A	N/A
Accuray Incorporated (ARAY)vs ›	$34.20M	N/A	4.27%	2.75%	3.74%
Aligos Therapeutics, Inc. (ALGS)vs ›	$33.66M	N/A	N/A	N/A	N/A
BriaCell Therapeutics Corp. (BCTX)vs ›	$35.10M	N/A	N/A	N/A	N/A
Elutia Inc (ELUT)vs ›	$35.15M	N/A	N/A	N/A	N/A
DocGo Inc. (DCGO)vs ›	$35.76M	N/A	15.63%	9.19%	7.93%
EUDA Health Holdings Limited (EUDA)vs ›	$32.91M	N/A	0.01%	0.01%	0.01%
Rockwell Medical, Inc. (RMTI)vs ›	$32.64M	N/A	5.17%	5.17%	5.17%
HeartBeam, Inc. (BEAT)vs ›	$32.34M	N/A	N/A	N/A	N/A
Scilex Holding Company (SCLX)vs ›	$32.27M	N/A	N/A	N/A	N/A

EBITDA Yield Formula & Definition

EBITDA Yield = TTM EBITDA / Enterprise Value

EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EBITDA Yield: N/A

GRCE EBITDA Yield Metrics

GRCE Competitors' EBITDA Yield

EBITDA Yield Formula & Definition

Related Metrics